Novel fluorinated derivatives as EGFR inhibitors useful for treating cancers
- 专利权人:
- Trillium Therapeutics Inc.
- 发明人:
- Slassi, Abdelmalik,Dove, Peter
- 申请号：
- AU2016214923
- 公开号：
- AU2016214923A1
- 申请日:
- 2016.02.03
- 申请国别(地区):
- AU
- 年份:
- 2017
- 代理人:
- 摘要：
- A novel class of fluorinated derivatives of Formula I have been prepared and found to be useful in the treatment of cancers and other EGFR related disorders.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- NOVEL FLUORINATED DERIVATIVES AS EGFR INHIBITORS USEFUL FOR TREATING CANCERS
- NOVEL FLUORINATED DERIVATIVES AS EGFR INHIBITORS USEFUL FOR TREATING CANCERS
- NOVEL FLUORINATED DERIVATIVES AS EGFR INHIBITORS USEFUL FOR TREATING CANCERS
- Novel fluorinated quinazoline derivatives as EGFR inhibitors
- NOUVEAUX DERIVES DE QUINAZOLINE FLUORES UTILISES COMME INHIBITEURS DU RECEPTEUR DU FACTEUR DE CROISSANCE EPIDERMIQUE (EGFR)
